Vicapsys Life Sciences, Inc. (VICP)

USD 7.0

(0.0%)

Net Income Summary of Vicapsys Life Sciences, Inc.

Vicapsys Life Sciences, Inc.'s latest annual net income in 2023 was -1.18 Million USD , up 29.01% from previous year.
Vicapsys Life Sciences, Inc.'s latest quarterly net income in 2023 Q4 was -594.8 Thousand USD , down -147.48% from previous quarter.
Vicapsys Life Sciences, Inc. reported an annual net income of -1.66 Million USD in 2022, down -1116.66% from previous year.
Vicapsys Life Sciences, Inc. reported an annual net income of -136.87 Thousand USD in 2021, up 82.13% from previous year.
Vicapsys Life Sciences, Inc. reported a quarterly net income of -211.27 Thousand USD for 2023 Q1, up 74.63% from previous quarter.
Vicapsys Life Sciences, Inc. reported a quarterly net income of -240.34 Thousand USD for 2023 Q3, down -77.12% from previous quarter.

Annual Net Income Chart of Vicapsys Life Sciences, Inc. (2023 - 2008)

Historical Annual Net Income of Vicapsys Life Sciences, Inc. (2023 - 2008)

Year	Net Income	Net Income Growth
2023	-1.18 Million USD	29.01%
2022	-1.66 Million USD	-1116.66%
2021	-136.87 Thousand USD	82.13%
2020	-765.84 Thousand USD	45.67%
2019	-1.4 Million USD	35.98%
2018	-2.2 Million USD	31.91%
2017	-3.23 Million USD	0.0%
2009	-1.66 Million USD	31.49%
2008	-2.43 Million USD	0.0%

Year	Net Income	Net Income Growth
2023 Q4	-594.8 Thousand USD	-147.48%
2023 Q1	-211.27 Thousand USD	74.63%
2023 Q3	-240.34 Thousand USD	-77.12%
2023 Q2	-135.69 Thousand USD	35.77%
2022 FY	-1.66 Million USD	-1116.66%
2022 Q2	-180.05 Thousand USD	-7.79%
2022 Q3	-145.08 Thousand USD	19.42%
2022 Q4	-832.83 Thousand USD	-474.05%
2022 Q1	-167.04 Thousand USD	-60.84%
2021 Q2	-72.06 Thousand USD	-243.46%
2021 FY	-136.87 Thousand USD	82.13%
2021 Q4	-103.85 Thousand USD	6.59%
2021 Q3	-111.18 Thousand USD	-54.29%
2021 Q1	50.23 Thousand USD	162.36%
2020 Q3	-89.22 Thousand USD	61.48%
2020 Q2	-231.61 Thousand USD	36.45%
2020 FY	-765.84 Thousand USD	45.67%
2020 Q1	-364.45 Thousand USD	-46.0%
2020 Q4	-80.54 Thousand USD	9.72%
2019 Q2	-248.06 Thousand USD	43.96%
2019 FY	-1.4 Million USD	35.98%
2019 Q4	-249.63 Thousand USD	46.81%
2019 Q3	-469.34 Thousand USD	-89.2%
2019 Q1	-442.65 Thousand USD	-427.86%
2018 Q4	-83.85 Thousand USD	0.0%
2018 FY	-2.2 Million USD	31.91%
2017 FY	-3.23 Million USD	0.0%
2010 Q1	-662.33 Thousand USD	-36467.58%
2010 Q2	-347.42 Thousand USD	47.54%
2009 FY	-1.66 Million USD	31.49%
2009 Q4	-1811.26 USD	0.0%
2009 Q2	-530.39 Thousand USD	-67.35%
2009 Q1	-316.93 Thousand USD	0.0%
2008 FY	-2.43 Million USD	0.0%

Peer Net Income Comparison of Vicapsys Life Sciences, Inc.

Name	Net Income	Net Income Difference
America Great Health	-761.42 Thousand USD	-55.251%
Gene Biotherapeutics, Inc.	- USD	Infinity%
Evolutionary Genomics, Inc.	-2.24 Million USD	47.421%
Innovation1 Biotech Inc.	-5.98 Million USD	80.26%
Point of Care Nano-Technology, Inc.	-78.01 Thousand USD	-1415.198%